Morgan Stanley’s BioRestorative Therapies BRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3K | Sell |
35,000
-3,000
| -8% | -$5K | ﹤0.01% | 6306 |
|
|
2025
Q1 | $67.6K | Buy |
38,000
+10,500
| +38% | +$18.7K | ﹤0.01% | 6171 |
|
|
2024
Q4 | $39.3K | Buy |
27,500
+10,000
| +57% | +$14.3K | ﹤0.01% | 6364 |
|
|
2024
Q3 | $30.5K | Buy |
17,500
+2,500
| +17% | +$4.35K | ﹤0.01% | 6364 |
|
|
2024
Q2 | $30.5K | Buy |
15,000
+5,000
| +50% | +$10.2K | ﹤0.01% | 6330 |
|
|
2024
Q1 | $13.8K | Buy |
+10,000
| New | +$13.8K | ﹤0.01% | 6584 |
|
|
2022
Q2 | – | Sell |
-25
| Closed | – | – | 7814 |
|
|
2022
Q1 | $0 | Buy |
+25
| New | – | ﹤0.01% | 7969 |
|